Article
Applied Clinical Trials
Terrorist Attacks Have No Impact on DIA EuroMeeting
Author(s):
The EuroMeeting and Clinical Forum will take place in Paris as planned, in spite of January’s terrorist attacks in the French capital.
The EuroMeeting and Clinical Forum will take place in Paris as planned, in spite of January’s terrorist attacks in the French capital, according to the Drug Information Association (DIA).
“We are working closely with the venue and the city of Paris to make sure all security measures are taken and onsite security will be reinforced,” noted Natacha Scholl, Team Leader of Operations for DIA in Europe, Middle East & Africa. “We will put everything in place to reassure participants of course.”
She does not anticipate that the attacks will have any great impact on delegate numbers. “Registrations haven't stopped over the past days, despite the tragic events,” she remarked.
As of January 15, there were already more than 650 registered participants, and Scholl said the organizers are expecting at least 2500 to 3000 attendees in total for the two events.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
